You can apply to the Neurosciences and Mental Health Board through four of our grant schemes.
The sponsors of the UKRMP have issued a call for ‘Challenge Ideas’ to provide an opportunity for all interested parties to highlight scientific areas, generic technologies and platform approaches that would significantly advance the overall mission of the Platform in its next phase.
Building on the world-leading MRC/AstraZeneca Mechanisms of Disease Call in which 15 high quality experimental medicine grants were awarded, the MRC is now working with 6 industry partners (AstraZeneca, GSK, J&J, Pfizer, Takeda and UCB) to provide researchers access to their deprioritised compounds.
Keep up to date with changes by signing up to receive email alerts.
The Confidence in Concept scheme is a key part of MRC’s translational research strategy and provides annual awards of £250k-£1.2m to institutions, to be used flexibly to support the earliest stages of multiple translational research projects.
Proximity to Discovery: Industry Engagement Fund is designed to provide flexible funding for innovative ways to enable the initial development of academic-industry collaborations.
The Tools and Resources Development Fund (TRDF) aims to pump prime the next generation of tools, technologies and resources that will be required by bioscience researchers.
Stratified Medicine is a priority area for the MRC. We currently have significant investment in this area of research. Researchers are now invited to submit outline proposals for funding for the development of further disease-focussed consortia to stratify disease.
The Medical Research Foundation and Medical Research Council will make available up to £2 million for new high-quality, internationally competitive research partnerships to investigate the underlying bio-psycho-social mechanistic and environmental drivers.